Adds details throughout
May 13 (Reuters) - Digital health startup Hinge Health said on Tuesday it is targeting a valuation of up to $2.6 billion in its initial public offering on the New York Stock Exchange, signaling a thawing IPO market after recent market volatility.
Financial markets have regained footing in recent weeks as the de-escalation of U.S.-China trade tensions has rekindled expectations for a resurgence in dealmaking activity.
The San Francisco, California-based company, along with existing stockholders, plans to raise over $437 million by offering 13.7 million shares priced between $28 and $32 each.
Even at the top of its proposed range, Hinge Health's IPO represents a nearly 60% reduction from its 2021 Series E valuation of $6.2 billion, led by Coatue Management and Tiger Global.
While a widely expected IPO market recovery is yet to materialize, defensive sectors like healthcare have been resilient, with healthcare companies accounting for 23% of all IPOs in Q1 2025, according to an Ernst & Young report.
Last week, Apollo-backed Aspen Insurance's AHL.N shares rose nearly 11% in its NYSE debut, while virtual chronic care provider Omada filed to list on Nasdaq.
Founded in 2014 by Daniel Perez and Gabriel Mecklenburg, Hinge Health's platform offers musculoskeletal care, addressing acute injuries, chronic pain management, and post-surgical rehabilitation.
Rising concerns over Americans' sedentary lifestyles and dietary choices have driven demand for improved healthcare options.
Hinge Health's revenue climbed to $123.8 million in the first quarter of 2025, marking a nearly 50% increase from the previous year. The company also reported a profit of $17 million compared with a loss of over $26 million in the previous year.
Morgan Stanley, Barclays Capital, and BofA Securities are the lead underwriters for the offering.
The company will list on the NYSE under the symbol "HNGE".
(Reporting by Ateev Bhandari in Bengaluru; Editing by Vijay Kishore and Tasim Zahid)
((Ateev.Bhandari@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.